New Lifetime High Today: Synageva BioPharma (GEVA)

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer.

Trade-Ideas LLC identified Synageva BioPharma ( GEVA) as a new lifetime high candidate. In addition to specific proprietary factors, Trade-Ideas identified Synageva BioPharma as such a stock due to the following factors:

  • GEVA has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $127.9 million.
  • GEVA has traded 38,060 shares today.
  • GEVA is trading at a new lifetime high.

EXCLUSIVE OFFER: Get the inside scoop on opportunities in GEVA with the Ticky from Trade-Ideas. See the FREE profile for GEVA NOW at Trade-Ideas

More details on GEVA:

Synageva BioPharma Corp. operates as a biopharmaceutical company in the United States. It focuses on the discovery, development, and commercialization of therapeutic products for patients with rare diseases.

The average volume for Synageva BioPharma has been 261,700 shares per day over the past 30 days. Synageva BioPharma has a market cap of $3.0 billion and is part of the health care sector and drugs industry. The stock has a beta of -0.05 and a short float of 15.1% with 3.37 days to cover.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

If you liked this article you might like

The Nominees for Best Biopharma CEO of 2015 Are...

The Nominees for Best Biopharma CEO of 2015 Are...

Bluebird, Pacira Pharmaceuticals Excite Life Science Investors

Bluebird, Pacira Pharmaceuticals Excite Life Science Investors

Bluebird, Pacira Pharmaceuticals Gain Steam in Burgeoning Life Science Space

Bluebird, Pacira Pharmaceuticals Gain Steam in Burgeoning Life Science Space

Where the Money Was Made the Last 5 Years

Where the Money Was Made the Last 5 Years